Pharmaceutical composition of nilotinib

Pharmaceutical composition of nilotinib

A method of treating leukaemia comprising orally administering to a patient in need thereof reduced daily doses of nilotinib of 100 mg to 600 mg, wherein the nilotinib is administered in a dosage formhaving a composition comprising nilotinib butanedisulphonate (2:1) or nilotinib butanedisulphonate (...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: JAHAGIRDAR HARSHAL, THENNATI RAJAMANNAR, KULKARNI AMOL, JADHAV BHUSHAN, KULKARNI SHIRISH
Format: Patent
Sprache:chi ; eng
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A method of treating leukaemia comprising orally administering to a patient in need thereof reduced daily doses of nilotinib of 100 mg to 600 mg, wherein the nilotinib is administered in a dosage formhaving a composition comprising nilotinib butanedisulphonate (2:1) or nilotinib butanedisulphonate (1:1). 种治疗白血病的方法，包括向需要其的患者口服给予100mg至600mg的减少的日剂量的尼洛替尼，其中尼洛替尼以具有包含尼洛替尼丁烷二磺酸盐(2：1)或尼洛替尼丁烷二磺酸盐(1：1)的组合物的剂型给予。